1. A rare and fatal respiratory disease: bronchial Dieulafoy’s disease
- Author
-
Yao Ouyang, Shi-Xia Liao, Shuang-Fei He, Bang-Guo Li, Peng-Peng Sun, and Mao-Mao Liu
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,bronchoscopy ,Dieulafoy’s disease of the bronchus ,Pulsatile flow ,Case Report ,hemoptysis ,03 medical and health sciences ,0302 clinical medicine ,Bronchoscopy ,vascular deformity ,medicine ,Pharmacology (medical) ,lcsh:RC705-779 ,Thesaurus (information retrieval) ,medicine.diagnostic_test ,business.industry ,General surgery ,Respiratory disease ,lcsh:Diseases of the respiratory system ,respiratory system ,medicine.disease ,respiratory tract diseases ,030228 respiratory system ,030220 oncology & carcinogenesis ,Dieulafoy s disease ,business ,computed tomography angiography of bronchial artery - Abstract
A 66-year-old woman had two severe episodes of massive hemoptysis without any premonitory symptoms, with approximately 400–500 ml blood each time. Bronchoscopic exam revealed a smooth and pulsatile protrusion that was approximately 8–10 mm in diameter found at the beginning of the right middle lobe bronchus in the bronchial lumen. The protrusion arose from the surface with absolutely normal mucosa. Selective bronchial arteriography showed that elongated, tortuous, and dilated branches of the bronchial artery in the region of the middle lobe bronchus. Further bronchial arterial embolization (BAE) is recommended, although the patient currently has no active bleeding. Bronchial Dieulafoy’s disease (BDD) is a rare and life-threatening disease. Selective bronchial arteriography is a diagnostic tool to detect and locate abnormal arteries. There is no unified guideline or expert consensus on the treatment of BDD. Selective BAE or surgical resection is usually used as a first-line treatment to control hemoptysis. The reviews of this paper are available via the supplemental material section.
- Published
- 2020